At Forbion, biotech innovation focuses on improving patients' lives. However, the connection between groundbreaking science and the people it serves is not always visible.
Our Portfolio Company Spotlight series bridges that gap by bringing together the voices behind scientific innovation and those living with the diseases it aims to treat.
Episode 1 spotlights VectorY. Hear from Dr. Olga Uspenskaya, Chief Medical Officer at VectorY, Marcel Didden, PhD, a patient living with ALS and Prof. Leonard van den Berg, a distinguished faculty professor of neurology at the UMC Utrecht Brain Center; Director of the Netherlands ALS Centre; Chair of ENCALS & TRICALS.
Together, they share a powerful story that connects lived experience, cutting-edge science, and the clinical advances shaping the future of ALS treatment.
Through our Portfolio Company Spotlight series, we want to showcase the real-world impact of the diseases addressed by our portfolio companies, highlight the scientific innovation driving the next generation of therapies, and emphasise the vital role of patient perspectives in advancing research and clinical development.